HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Ouvert

SecteurFinance

210.4 3.24

Résumé

Variation du prix de l'action

24h

Actuel

Min

204

Max

210.8

Chiffres clés

By Trading Economics

Revenu

-34M

71M

Ventes

85M

1.3B

P/E

Moyenne du Secteur

29.8

22.989

BPA

0.08

Rendement du dividende

3.47

Marge bénéficiaire

5.575

Employés

10,910

EBITDA

57M

338M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+44.01% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

3.47%

4.69%

Prochains Résultats

4 août 2026

Date du Prochain Détachement de Dividende

20 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-793M

4.1B

Ouverture précédente

207.16

Clôture précédente

210.4

Sentiment de l'Actualité

By Acuity

50%

50%

157 / 439 Classement par Finance

ConvaTec Group PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

À Propos ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat